Key Pharmaceuticals
Key Pharmaceuticals is an independent, Australian-owned consumer healthcare company that develops, in-licenses and distributes a portfolio of 18+ OTC brands across pharmacy, wholesale, grocery and export channels in Australia and New Zealand.
- Company typePrivate
- Founded1985
- HeadquartersPort Macquarie, Australia
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Key Pharmaceuticals does
Key Pharmaceuticals is an independent, Australian-owned consumer healthcare company founded in 1985 that develops, in-licenses, distributes and markets over-the-counter (OTC) medicines, complementary medicines, medical devices, dermocosmetics and personal care products across Australia and New Zealand, with additional export distribution. The company operates a portfolio of 18+ established brands organised into categories including digestion (Mintec, OsmoLax, Gasbusters, Charco, DIAREZE), ear health (Earclear), pregnancy (Pregnosis), skin and haircare (Hamilton, Blistex, Nizoral, Hair A-Gain, NeutraLice), vitamins (OsteVit-D, including the once-a-week format) and other health products (TravaCalm, TravaEase, No-Doz, Odor-Eaters, Stud-100). Notable brand positions include TravaCalm as Australia's #1 motion sickness brand and OsteVit-D as the first Australian Vitamin D3 brand, the latter delivering an 8% long-term CAGR accelerating to 14% in recent years.
The business model is a brand-owner and in-licensing/distribution model: Key Pharmaceuticals acquires or licenses brands, then deploys in-house capabilities across marketing, sales, regulatory affairs, quality assurance, supply chain and R&D to commercialise them. Products are sold through dedicated sales teams into pharmacy (primary), wholesale, grocery and export channels, with national coverage in every Australian state. The company is sales-led, with brand growth driven by a combination of healthcare professional engagement, consumer TV advertising (e.g. OsteVit-D), in-store merchandising and data-driven consumer and market insights. Quality and regulatory credentials include ISO 9001, ISO 13485, GMP compliance and Halal certification, supporting operation across listed medicines, medical devices and complementary medicines. The company is privately held under family ownership (Sherry Gregory, Director and Proprietor), led by CEO Meelian Hoh, and operates from a new headquarters in Macquarie Park, NSW with 51-100 employees.
Key Pharmaceuticals firmographics
Firmographics- Name
- Key Pharmaceuticals
- Legal name
- Key Pharmaceuticals Pty Ltd
- Website
- https://keypharm.com.au
- Company type
- Private
- Founded year
- 1985
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Key Pharmaceuticals is an independent, Australian-owned consumer healthcare company that develops, in-licenses and distributes a portfolio of 18+ OTC brands across pharmacy, wholesale, grocery and export channels in Australia and New Zealand.
- Ownership category
- akta.pro rank
Key Pharmaceuticals industry classification
Industry- Product category
- Consumer Healthcare (OTC Pharmaceuticals)
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (4242), Pharmacies and Drug Retailers (45611)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
- akta.pro secondary industries
- Eye, Ear & Nasal Care OTC (Eye Drops, Ear Drops/Wax Removal, Saline Sprays) (CRADAMAG), Gastrointestinal & Digestive Health (HLAIADAD), Eye, Ear & Nasal Care (HLAIADAF), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)
Keywords
Where Key Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Port Macquarie
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Key Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D, Infrastructure
Revenue model
- Product Sales: Key Pharmaceuticals generates revenue through the sale of consumer healthcare products including OTC medicines, complementary medicines, medical devices, dermocosmetics and personal care products across pharmacy, wholesale, grocery and export channels.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Key Pharmaceuticals product offering
Product offeringCore offering
Key Pharmaceuticals develops, markets, and distributes over-the-counter (OTC) consumer healthcare products including medicines, complementary medicines, medical devices, dermocosmetics, and personal care items. The company operates as a brand owner and in-licensing/distribution company, managing a portfolio of trusted Australian brands such as OsteVit-D, Blistex, Nizoral, Hamilton, TravaCalm, EarClear, and No-Doz across pharmacy, wholesale, grocery, and export channels in Australia and New Zealand.
Product overview
Key Pharmaceuticals develops and markets consumer healthcare products sold over-the-counter (OTC), including OTC medicines, complementary medicines, medical devices, dermocosmetics, and personal care products. The company operates as a portfolio of brands spanning multiple health categories including digestion (Mintec, OsmoLax, Gasbusters, Charco, DIAREZE), ear health (Earclear), pregnancy (Pregnosis), skin and haircare (Hamilton Sun, Hamilton Urederm, Blistex, Nizoral, Hair A-Gain, NeutraLice), vitamins (OsteVit-D), and other health products (TravaCalm, TravaEase, No-Doz, Odor-Eaters, Stud-100). The company markets and distributes products through pharmacy, wholesale, grocery and export channels across Australia and New Zealand, with expertise in in-licensing, acquisitions, distribution, collaboration and innovation.
Differentiator
Problem solved
Functional benefit
Brands
- Blistex: Expert lip care with advanced hydration and protection to keep lips healthy, smooth, and nourished.
- Nizoral
- Hamilton
- TravaCalm
- TravaEase
- Earclear
- OsteVit-D
- No-Doz
- Mintec
- OsmoLax
- Gasbusters
- Charco
- DIAREZE
- Odor-Eaters
- Hair A-Gain
- NeutraLice
- Pregnosis
- Stud-100
Products and services
- OsteVit-D Essential vitamin D supplement to support bone health, immune function, and calcium absorption for overall well-being, including a once-weekly formulation. Australia's first Vitamin D3 brand.
- Blistex Expert lip care brand delivering advanced hydration and protection to keep lips healthy, smooth, and nourished.
- Nizoral Clinically proven anti-dandruff shampoo containing ketoconazole, a broad-spectrum antifungal agent.
- Hamilton Sun Trusted Australian sun protection with SPF50+, lightweight feel, and dermatologist-tested care.
- Hamilton Urederm Proven hydration for dry, sensitive skin formulated to restore and strengthen the skin barrier.
- TravaCalm Australia's #1 motion sickness brand offering a range of motion sickness products for relief during travel.
- TravaEase Passionflower-based product traditionally used in Western herbal medicine to relieve symptoms of mild anxiety.
- EarClear Australian-owned brand specializing in ear care, offering products for ear wax removal and soothing solutions for healthier ears.
- No-Doz Low calorie caffeine supplements to help boost concentration and enhance mental alertness.
- Mintec Peppermint oil IBS relief containing medicinal grade peppermint oil, a natural antispasmodic that relieves symptoms of medically diagnosed IBS including abdominal pain, bloating, cramping, and spasms.
- OsmoLax Relief Flavour-free laxative that dissolves clearly when mixed with hot or cold drinks, gently softening and easing stool to promote controlled bowel movements.
- Gasbusters High strength peppermint flavoured softgel capsules for relief of stomach wind discomfort, gas, and bloating.
- Charco (Charcocaps) Activated charcoal capsules that relieve excess intestinal gas, bloating and flatulence, with no added artificial flavours, gluten, salt, lactose, or sucrose.
- DIAREZE Effective relief from symptoms of acute non-specific diarrhoea.
- Hair A-Gain Topical minoxidil application for the treatment of hereditary pattern baldness in men and women, available without prescription at pharmacies.
- NeutraLice Fast and effective head lice treatment clinically proven to kill head lice, suitable for those with sensitive skin.
- Pregnosis Fast, accurate pregnancy test for detecting pregnancy at home.
- Stud-100 Delay spray for men containing a local anaesthetic that reduces tactile sensitivity of the penis to delay ejaculation.
- Odor-Eaters Foot odour and wetness control products containing ingredients for destroying odour and controlling wetness.
Quantifiable outcome
- 8% long-term CAGR for OsteVit-D with 14% growth in recent years
- +1 more outcomes
Companies that use Key Pharmaceuticals
Customer profileSegments4 records
Ideal customer profiles4 records
Key Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Key Pharmaceuticals partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Brand Owners & SupplierscoreKey Pharmaceuticals partners with brand owners and suppliers through in-licensing, distribution agreements and collaboration. They apply their full-range of in-house capabilities including marketing, sales, regulatory, quality assurance, supply chain and R&D to ensure partner brand success. The company is always looking for new products and invites proposals from companies seeking a commercialization partnership.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Key Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Ego Pharmaceuticals: Australian, family-owned independent consumer healthcare brand owner specializing in dermatology and OTC skincare sold through pharmacy and grocery. Closely comparable in operating model, governance (private family), and channel mix to Key Pharmaceuticals.
- iNova Pharmaceuticals: Australia/NZ consumer healthcare company owning a portfolio of OTC and personal care brands (e.g., Nurofen-trademark-adjacent, pain, weight management). Directly comparable as a brand-owner/distributor in ANZ consumer health.
- PharmaCare Laboratories: Australian-owned OTC and consumer health company marketing and distributing brands such as Nature's Own, Cenovis and Bio-organics through pharmacy and grocery, with ANZ distribution and brand management model comparable to Key Pharmaceuticals.
- Care Pharmaceuticals: Australian OTC consumer health brand owner with in-licensing, distribution and a multi-brand portfolio sold through pharmacy and grocery. Operates at comparable scale and channel mix in the same ANZ OTC market as Key Pharmaceuticals.
Broad incumbents
- Haleon (ANZ): Global OTC consumer health major (formerly GSK Consumer Healthcare) with deep ANZ presence in pain, oral care, vitamins (Centrum) and respiratory OTCs. Competes with Key Pharma across multiple categories at the same pharmacy and grocery shelves.
- Blackmores Group: Australia's largest vitamins, supplements and natural health brand owner, now part of Kirin Holdings. Competitor in the vitamins/wellness category (overlapping with OsteVit-D) and a similar ANZ consumer health brand owner, but materially larger and broader in portfolio.
- Reckitt Benckiser (ANZ): Global OTC and FMCG major with ANZ consumer health brands (e.g., Nurofen, Strepsils, Gaviscon, Dettol). Sells through the same pharmacy/grocery channels and competes directly in the OTC categories where Key Pharma operates.
- Bayer Consumer Health (ANZ): Global consumer health division of Bayer, with ANZ OTC brands in pain, allergy, sun protection and dermatology. Competes with Key Pharma in OTC medicines and skin care categories via pharmacy and grocery.
- Swisse Wellness: Australian vitamins and supplements brand now owned by H&H Group, operating at significantly larger scale than Key Pharma but competing for the same health-conscious ANZ consumer through pharmacy and grocery channels.
Regional players
- Bod Science: Australian-listed small-cap consumer health/CBD wellness company. Comparable as an Australian-listed peer in consumer health, though materially smaller and not a direct channel competitor in OTC medicines.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Key Pharmaceuticals social profiles
Digital presenceKey Pharmaceuticals compliance and trust
Trust signalCompliance2 records
Key Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Key Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles10 records
Key Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Key Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Key Pharmaceuticals
What does Key Pharmaceuticals do?
Key Pharmaceuticals develops, markets, and distributes over-the-counter (OTC) consumer healthcare products including medicines, complementary medicines, medical devices, dermocosmetics, and personal care items. The company operates as a brand owner and in-licensing/distribution company, managing a portfolio of trusted Australian brands such as OsteVit-D, Blistex, Nizoral, Hamilton, TravaCalm, EarClear, and No-Doz across pharmacy, wholesale, grocery, and export channels in Australia and New Zealand.
Is Key Pharmaceuticals a public or private company?
Key Pharmaceuticals is a private company. It is classified as family owned and is currently operating.
When was Key Pharmaceuticals founded?
Key Pharmaceuticals was founded in 1985. It employs 51 to 100 people.
Where is Key Pharmaceuticals based?
Key Pharmaceuticals is headquartered in Port Macquarie, Australia, in the Oceania region.
How does Key Pharmaceuticals make money?
One revenue line is on record: product Sales.
Who are Key Pharmaceuticals's main competitors?
Direct peers on record are Ego Pharmaceuticals, iNova Pharmaceuticals, PharmaCare Laboratories and Care Pharmaceuticals. Broad incumbents are Haleon (ANZ), Blackmores Group, Reckitt Benckiser (ANZ), Bayer Consumer Health (ANZ) and Swisse Wellness. Bod Science is listed as a regional player.
Does Key Pharmaceuticals have an API?
No public API is recorded for Key Pharmaceuticals.
What industry is Key Pharmaceuticals in?
Key Pharmaceuticals's product category is Consumer Healthcare (OTC Pharmaceuticals). Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of CRADAMAG, Eye, Ear & Nasal Care OTC (Eye Drops, Ear Drops/Wax Removal, Saline Sprays). Its NAICS code is 424210 and its SIC code is 5122.